FRANKLIN, Mass.--(BUSINESS WIRE)--In accordance with the new guidelines issued by the American Society of Anesthesiologists to improve the perioperative care and reduce the risk of adverse outcomes in patients with Obstructive Sleep Apnea (OSA),
Itamar-Medical’s WatchPAT device for home sleep testing is already being
used to effectively deliver fast, patient-satisfying results for
pre-operative sleep testing.

“We believe that anesthesiologists everywhere will be excited about WatchPAT’s diagnostic precision, ease of use, and simple connectivity into their patient records.”

“Patients with undiagnosed sleep apnea have a higher complication rate, longer recovery, and poorer pain control,” said Dr. Marvin Tark, head of
the Pain Management Section and former Chairman of Anesthesia at
Wellstar Kennestone Hospital, Marietta, Georgia. “WatchPAT provides the
information we need to monitor and manage the patient better in both the
surgical and the post-operative period, offering the best possible
high-quality medical care. By using WatchPAT as part of our standard
pre-operative procedure, we are able to reduce peri-operative
complications, save time and money by minimizing time spent in the
recovery room, and more safely determine the course of pain management,
Having reviewed the medical evidence behind WatchPAT, I now recommend it
as the sleep test method of choice for all of our surgical patients.”

“With the new importance in anesthesiology now given to sleep testing, once again, we are glad to be the pioneers of home sleep testing in the
world of surgery,” said Dr. Dov Rubin, President & CEO, Itamar-Medical.
“We believe that anesthesiologists everywhere will be excited about
WatchPAT’s diagnostic precision, ease of use, and simple connectivity
into their patient records.”

WatchPAT is the most scientifically investigated and tested ambulatory device for Obstructive Sleep Apnea (OSA). It offers physicians the
ability to fully analyze the 6 channels of tamper-proof raw
sleep-related data and manually override the suggested automatic
analysis in a manner similar to standard PSG recordings. Used by
physicians worldwide on over 200,000 patients, WatchPAT has made
Itamar-Medical the leader in home sleep testing.

WatchPAT is the most scientifically investigated ambulatory device for Obstructive Sleep Apnea. It is easily installed by the patients in the
comfort of their own home. WatchPAT is the only portable device
providing Apnea-Hypopnea Index (AHI), Respiratory Disturbance Index
(RDI), and Oxygen Desaturation Index (ODI) based on actual sleep time
and sleep states without a cumbersome nasal cannula, awkward belt around
the chest, and EEG/EOG electrodes or other devices sticking to the head.
WatchPAT offers the patient greater comfort, more natural sleep, as well
as an amazingly low failure rate. Itamar’s intuitive software enables
sleep physicians to review the data and manually override any and all of
the automatic scoring (the actual sleep data cannot be changed).
WatchPAT’s newest features include multi-night capability, tamper-proof
occupational testing, and seamless, web-based study upload to Electronic
Medical Records. Used by physicians worldwide on over 250,000 patients,
WatchPAT has made Itamar-Medical the leader in home sleep testing.